TSXV/ALZI (TSXV/ALZI)

TSX Venture Exchange: TSXV/ALZI · CAD

CA$0.20

+0.00 (0.0%)· Recorded snapshot

Market cap	13M
Revenue (ttm)	69.1K
Net income (ttm)	-4.1M
EPS (ttm)	-CA$0.08
Shares out	64.8M
Volume	0

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 69.1K
Net income (ttm): -4.1M
EPS (ttm): -CA$0.08
Market cap: 13M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TSXV/ALZI indicators

Market & fundamental data

Available fields

115

Groups with data

Currency

CAD

Showing 115 of 115 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-26
Enterprise value	CAD 11.6M
Exchange	TSX Venture Exchange
Financial currency	CAD
Financial report date	2026-07-31
First seen	2026-07-12
Fiscal year end	April
Founded	2024
Industry	Biotechnology
Is primary listing	Yes
ISIN number	CA02262P1036
Last refreshed	2026-10-28
Market cap	CAD 13M
Next earnings date	2026-11-26
Price	CAD 0.20
Price currency	CAD
Sector	Healthcare
SIC code	8099
Stock price date	2026-10-27
Symbol	tsxv/ALZI
Website	https://alzaihealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-37.98%
EV/Sales	168.47x
FCF / EV yield	-32.18%
FCF yield	-28.91%
P/B ratio	8.51x
P/S ratio	187.58x
Price / tangible book value	9.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Operating margin	-5,783.6%
Pretax margin	-5,981.44%
ROCE	-189.27%
SBC / revenue	954.08%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -17,806
Depreciation and amortization	CAD -213
EBIT	CAD -4M
EBITDA	CAD -4M
EPS	CAD -0.08
FCF per share	CAD -0.06
Financing cash flow	CAD 4.1M
Free cash flow	CAD -3.7M
Free cash flow minus SBC	CAD -4.4M
Gross profit	CAD -480,367
Investing cash flow	CAD -17,806
Net borrowing	CAD 860,158
Net cash flow	CAD 338,869
Net income	CAD -4.1M
Operating cash flow minus SBC	CAD -4.4M
Operating income	CAD -4M
Revenue	CAD 69,087
Stock-based compensation	CAD 659,145

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	9.02
Book value per share	CAD 0.02
Debt / equity	0.39
Interest coverage	-42.42
Long-term assets	CAD 443,723
Long-term liabilities	CAD 587,805
Net cash (debt)	CAD 1.3M
Net cash / market cap	10.18%
Net cash growth	-15.87%
Net debt / equity	-0.87
Piotroski F-Score	1
Property, plant and equipment	CAD 15,276
Shareholders' equity	CAD 1.5M
Tangible book value	CAD 1.4M
Tangible book value per share	CAD 0.02
Total assets	CAD 2.6M
Total cash	CAD 1.9M
Total debt	CAD 587,805
Total liabilities	CAD 1M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	CAD 2.1M
Current liabilities	CAD 460,567
Current ratio	4.62
Net working capital	CAD -240,131
Quick ratio	4.54
Working capital	CAD 1.7M
Working capital turnover	0.05

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	0%
1M price change	-45.95%
1M total return	-45.95%
1W price change	-21.57%
1W total return	-21.57%
20-day SMA	CAD 0.31
3M price change	-48.72%
3M total return	-48.72%
52-week high	CAD 0.50
52-week high date	2026-06-25
52-week low	CAD 0.20
52-week low date	2026-10-27
All-time high	CAD 0.50
All-time high date	2026-06-22
All-time low	CAD 0.20
All-time low date	2026-10-27
Average true range (ATR)	CAD 0.02
Average volume	60.7K
Beta (1Y)	-0.31
Change from 52-week high	-60%
Change from 52-week low	0%
Change from all-time high	-60%
Change from all-time low	0%
Monthly RSI	0
Previous close	CAD 0.20
Price vs 20-day SMA	-34.64%
Relative volume	0.41
RSI	24.11
Sharpe ratio	-2.94
Sortino ratio	-3.63
Volume	0
Weekly RSI	0

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	55.9M
Shares change (QoQ)	12.03%
Shares held by insiders	13.73%
Shares outstanding	64.8M

Deeper analysis on TSXV/ALZI

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSXV/ALZI report

Is a complete TSXV/ALZI research report available?

No complete published report is available for tsxv/ALZI (TSXV/ALZI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSXV/ALZI (TSXV/ALZI)

Price

Financial snapshot

Fair-value bridge

Latest news · TSXV/ALZI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSXV/ALZI indicators

Profile and market data

Valuation

Profitability

Financial statements

Financial strength

Liquidity

Performance and technicals

Ownership and float

Deeper analysis on TSXV/ALZI

Frequently asked questions